2016, Cilt 25, Sayı 0, Sayfa(lar) 187-190
Interstitial Pneumonitis After Everolimus Therapy for Renal Cell Carcinoma
DOI 10.5262/tndt.2016.46
Emre URHAN1, Can HÜZMELİ2, Ferhan CANDAN2, Derya SEVEN3, Cesur GÜMÜŞ3, Mansur KAYATAŞ2
1Cumhuriyet Üniversitesi Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Sivas, Türkiye
2Cumhuriyet Üniversitesi Tıp Fakültesi, Nefroloji Bilim Dalı, Sivas, Türkiye
3Cumhuriyet Üniversitesi Tıp Fakültesi, Radyoloji Anabilim Dalı, Sivas, Türkiye
Keywords: Everolimus, Renal cell carcinoma, Interstitial pneumonitis

Everolimus is an immunosuppressive agent belonging to the mTOR inhibitors group, used in solid organ transplantation and renal cell carcinomas. The use of inhibitors of the mTOR group in renal carcinomas is associated with many side effects, the potentially most severe being interstitial pneumonitis. A 76-year-old female patient presented with exertional dyspnea, fever and cough. In this report, we discuss a patient with everolimus-induced interstitial pneumonia with a review of the relevant literature.

Türk Nefroloji Derneği'nin yayın organıdır.